Global Asthma and COPD Drug Market Insights and Forecast to 2031

Report ID: 1197756 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Asthma and COPD Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Asthma and COPD Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Bronchodilators
        1.2.3 Anti-inflammatory Drugs
        1.2.4 Monoclonal Antibodies
        1.2.5 Combination Drugs
    1.3 Market by Application
        1.3.1 Global Asthma and COPD Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Asthma
        1.3.3 COPD
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Asthma and COPD Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Asthma and COPD Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Asthma and COPD Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Asthma and COPD Drug Sales by Region
        2.4.1 Global Asthma and COPD Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Asthma and COPD Drug by Region (2023-2028)
    2.5 Global Asthma and COPD Drug Revenue by Region
        2.5.1 Global Asthma and COPD Drug Revenue by Region (2017-2022)
        2.5.2 Global Asthma and COPD Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Asthma and COPD Drug Sales by Manufacturers
        3.1.1 Global Top Asthma and COPD Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Asthma and COPD Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Asthma and COPD Drug in 2021
    3.2 Global Asthma and COPD Drug Revenue by Manufacturers
        3.2.1 Global Asthma and COPD Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Asthma and COPD Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Asthma and COPD Drug Revenue in 2021
    3.3 Global Asthma and COPD Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Asthma and COPD Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Asthma and COPD Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Asthma and COPD Drug Sales by Type
        4.1.1 Global Asthma and COPD Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Asthma and COPD Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Asthma and COPD Drug Sales Market Share by Type (2017-2028)
    4.2 Global Asthma and COPD Drug Revenue by Type
        4.2.1 Global Asthma and COPD Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Asthma and COPD Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Asthma and COPD Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Asthma and COPD Drug Price by Type
        4.3.1 Global Asthma and COPD Drug Price by Type (2017-2022)
        4.3.2 Global Asthma and COPD Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Asthma and COPD Drug Sales by Application
        5.1.1 Global Asthma and COPD Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Asthma and COPD Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Asthma and COPD Drug Sales Market Share by Application (2017-2028)
    5.2 Global Asthma and COPD Drug Revenue by Application
        5.2.1 Global Asthma and COPD Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Asthma and COPD Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Asthma and COPD Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Asthma and COPD Drug Price by Application
        5.3.1 Global Asthma and COPD Drug Price by Application (2017-2022)
        5.3.2 Global Asthma and COPD Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Asthma and COPD Drug Market Size by Type
        6.1.1 North America Asthma and COPD Drug Sales by Type (2017-2028)
        6.1.2 North America Asthma and COPD Drug Revenue by Type (2017-2028)
    6.2 North America Asthma and COPD Drug Market Size by Application
        6.2.1 North America Asthma and COPD Drug Sales by Application (2017-2028)
        6.2.2 North America Asthma and COPD Drug Revenue by Application (2017-2028)
    6.3 North America Asthma and COPD Drug Market Size by Country
        6.3.1 North America Asthma and COPD Drug Sales by Country (2017-2028)
        6.3.2 North America Asthma and COPD Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Asthma and COPD Drug Market Size by Type
        7.1.1 Europe Asthma and COPD Drug Sales by Type (2017-2028)
        7.1.2 Europe Asthma and COPD Drug Revenue by Type (2017-2028)
    7.2 Europe Asthma and COPD Drug Market Size by Application
        7.2.1 Europe Asthma and COPD Drug Sales by Application (2017-2028)
        7.2.2 Europe Asthma and COPD Drug Revenue by Application (2017-2028)
    7.3 Europe Asthma and COPD Drug Market Size by Country
        7.3.1 Europe Asthma and COPD Drug Sales by Country (2017-2028)
        7.3.2 Europe Asthma and COPD Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Asthma and COPD Drug Market Size by Type
        8.1.1 Asia Pacific Asthma and COPD Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Asthma and COPD Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Asthma and COPD Drug Market Size by Application
        8.2.1 Asia Pacific Asthma and COPD Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Asthma and COPD Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Asthma and COPD Drug Market Size by Region
        8.3.1 Asia Pacific Asthma and COPD Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Asthma and COPD Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Asthma and COPD Drug Market Size by Type
        9.1.1 Latin America Asthma and COPD Drug Sales by Type (2017-2028)
        9.1.2 Latin America Asthma and COPD Drug Revenue by Type (2017-2028)
    9.2 Latin America Asthma and COPD Drug Market Size by Application
        9.2.1 Latin America Asthma and COPD Drug Sales by Application (2017-2028)
        9.2.2 Latin America Asthma and COPD Drug Revenue by Application (2017-2028)
    9.3 Latin America Asthma and COPD Drug Market Size by Country
        9.3.1 Latin America Asthma and COPD Drug Sales by Country (2017-2028)
        9.3.2 Latin America Asthma and COPD Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Asthma and COPD Drug Market Size by Type
        10.1.1 Middle East and Africa Asthma and COPD Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Asthma and COPD Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Asthma and COPD Drug Market Size by Application
        10.2.1 Middle East and Africa Asthma and COPD Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Asthma and COPD Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Asthma and COPD Drug Market Size by Country
        10.3.1 Middle East and Africa Asthma and COPD Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Asthma and COPD Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Boehringer Ingelheim
        11.1.1 Boehringer Ingelheim Corporation Information
        11.1.2 Boehringer Ingelheim Overview
        11.1.3 Boehringer Ingelheim Asthma and COPD Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Boehringer Ingelheim Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Boehringer Ingelheim Recent Developments
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Corporation Information
        11.2.2 GlaxoSmithKline Overview
        11.2.3 GlaxoSmithKline Asthma and COPD Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GlaxoSmithKline Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GlaxoSmithKline Recent Developments
    11.3 Merck and Co
        11.3.1 Merck and Co Corporation Information
        11.3.2 Merck and Co Overview
        11.3.3 Merck and Co Asthma and COPD Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Merck and Co Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck and Co Recent Developments
    11.4 Novartis AG
        11.4.1 Novartis AG Corporation Information
        11.4.2 Novartis AG Overview
        11.4.3 Novartis AG Asthma and COPD Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Novartis AG Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Novartis AG Recent Developments
    11.5 AstraZeneca
        11.5.1 AstraZeneca Corporation Information
        11.5.2 AstraZeneca Overview
        11.5.3 AstraZeneca Asthma and COPD Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 AstraZeneca Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 AstraZeneca Recent Developments
    11.6 F. Hoffmann-La Roche
        11.6.1 F. Hoffmann-La Roche Corporation Information
        11.6.2 F. Hoffmann-La Roche Overview
        11.6.3 F. Hoffmann-La Roche Asthma and COPD Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 F. Hoffmann-La Roche Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 F. Hoffmann-La Roche Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Asthma and COPD Drug Industry Chain Analysis
    12.2 Asthma and COPD Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Asthma and COPD Drug Production Mode & Process
    12.4 Asthma and COPD Drug Sales and Marketing
        12.4.1 Asthma and COPD Drug Sales Channels
        12.4.2 Asthma and COPD Drug Distributors
    12.5 Asthma and COPD Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Asthma and COPD Drug Industry Trends
    13.2 Asthma and COPD Drug Market Drivers
    13.3 Asthma and COPD Drug Market Challenges
    13.4 Asthma and COPD Drug Market Restraints
14 Key Findings in The Global Asthma and COPD Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Asthma and COPD Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Bronchodilators
    Table 3. Major Manufacturers of Anti-inflammatory Drugs
    Table 4. Major Manufacturers of Monoclonal Antibodies
    Table 5. Major Manufacturers of Combination Drugs
    Table 6. Global Asthma and COPD Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Asthma and COPD Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Asthma and COPD Drug Sales by Region (2017-2022) & (MT)
    Table 9. Global Asthma and COPD Drug Sales Market Share by Region (2017-2022)
    Table 10. Global Asthma and COPD Drug Sales by Region (2023-2028) & (MT)
    Table 11. Global Asthma and COPD Drug Sales Market Share by Region (2023-2028)
    Table 12. Global Asthma and COPD Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Asthma and COPD Drug Revenue Market Share by Region (2017-2022)
    Table 14. Global Asthma and COPD Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Asthma and COPD Drug Revenue Market Share by Region (2023-2028)
    Table 16. Global Asthma and COPD Drug Sales by Manufacturers (2017-2022) & (MT)
    Table 17. Global Asthma and COPD Drug Sales Share by Manufacturers (2017-2022)
    Table 18. Global Asthma and COPD Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Asthma and COPD Drug Revenue Share by Manufacturers (2017-2022)
    Table 20. Asthma and COPD Drug Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 21. Global Asthma and COPD Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Asthma and COPD Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma and COPD Drug as of 2021)
    Table 23. Asthma and COPD Drug Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Asthma and COPD Drug Product Offered
    Table 25. Date of Manufacturers Enter into Asthma and COPD Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Asthma and COPD Drug Sales by Type (2017-2022) & (MT)
    Table 28. Global Asthma and COPD Drug Sales by Type (2023-2028) & (MT)
    Table 29. Global Asthma and COPD Drug Sales Share by Type (2017-2022)
    Table 30. Global Asthma and COPD Drug Sales Share by Type (2023-2028)
    Table 31. Global Asthma and COPD Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Asthma and COPD Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Asthma and COPD Drug Revenue Share by Type (2017-2022)
    Table 34. Global Asthma and COPD Drug Revenue Share by Type (2023-2028)
    Table 35. Asthma and COPD Drug Price by Type (2017-2022) & (USD/Kg)
    Table 36. Global Asthma and COPD Drug Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 37. Global Asthma and COPD Drug Sales by Application (2017-2022) & (MT)
    Table 38. Global Asthma and COPD Drug Sales by Application (2023-2028) & (MT)
    Table 39. Global Asthma and COPD Drug Sales Share by Application (2017-2022)
    Table 40. Global Asthma and COPD Drug Sales Share by Application (2023-2028)
    Table 41. Global Asthma and COPD Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Asthma and COPD Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Asthma and COPD Drug Revenue Share by Application (2017-2022)
    Table 44. Global Asthma and COPD Drug Revenue Share by Application (2023-2028)
    Table 45. Asthma and COPD Drug Price by Application (2017-2022) & (USD/Kg)
    Table 46. Global Asthma and COPD Drug Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 47. North America Asthma and COPD Drug Sales by Type (2017-2022) & (MT)
    Table 48. North America Asthma and COPD Drug Sales by Type (2023-2028) & (MT)
    Table 49. North America Asthma and COPD Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Asthma and COPD Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Asthma and COPD Drug Sales by Application (2017-2022) & (MT)
    Table 52. North America Asthma and COPD Drug Sales by Application (2023-2028) & (MT)
    Table 53. North America Asthma and COPD Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Asthma and COPD Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Asthma and COPD Drug Sales by Country (2017-2022) & (MT)
    Table 56. North America Asthma and COPD Drug Sales by Country (2023-2028) & (MT)
    Table 57. North America Asthma and COPD Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Asthma and COPD Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Asthma and COPD Drug Sales by Type (2017-2022) & (MT)
    Table 60. Europe Asthma and COPD Drug Sales by Type (2023-2028) & (MT)
    Table 61. Europe Asthma and COPD Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Asthma and COPD Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Asthma and COPD Drug Sales by Application (2017-2022) & (MT)
    Table 64. Europe Asthma and COPD Drug Sales by Application (2023-2028) & (MT)
    Table 65. Europe Asthma and COPD Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Asthma and COPD Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Asthma and COPD Drug Sales by Country (2017-2022) & (MT)
    Table 68. Europe Asthma and COPD Drug Sales by Country (2023-2028) & (MT)
    Table 69. Europe Asthma and COPD Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Asthma and COPD Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Asthma and COPD Drug Sales by Type (2017-2022) & (MT)
    Table 72. Asia Pacific Asthma and COPD Drug Sales by Type (2023-2028) & (MT)
    Table 73. Asia Pacific Asthma and COPD Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Asthma and COPD Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Asthma and COPD Drug Sales by Application (2017-2022) & (MT)
    Table 76. Asia Pacific Asthma and COPD Drug Sales by Application (2023-2028) & (MT)
    Table 77. Asia Pacific Asthma and COPD Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Asthma and COPD Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Asthma and COPD Drug Sales by Region (2017-2022) & (MT)
    Table 80. Asia Pacific Asthma and COPD Drug Sales by Region (2023-2028) & (MT)
    Table 81. Asia Pacific Asthma and COPD Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Asthma and COPD Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Asthma and COPD Drug Sales by Type (2017-2022) & (MT)
    Table 84. Latin America Asthma and COPD Drug Sales by Type (2023-2028) & (MT)
    Table 85. Latin America Asthma and COPD Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Asthma and COPD Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Asthma and COPD Drug Sales by Application (2017-2022) & (MT)
    Table 88. Latin America Asthma and COPD Drug Sales by Application (2023-2028) & (MT)
    Table 89. Latin America Asthma and COPD Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Asthma and COPD Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Asthma and COPD Drug Sales by Country (2017-2022) & (MT)
    Table 92. Latin America Asthma and COPD Drug Sales by Country (2023-2028) & (MT)
    Table 93. Latin America Asthma and COPD Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Asthma and COPD Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Asthma and COPD Drug Sales by Type (2017-2022) & (MT)
    Table 96. Middle East and Africa Asthma and COPD Drug Sales by Type (2023-2028) & (MT)
    Table 97. Middle East and Africa Asthma and COPD Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Asthma and COPD Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Asthma and COPD Drug Sales by Application (2017-2022) & (MT)
    Table 100. Middle East and Africa Asthma and COPD Drug Sales by Application (2023-2028) & (MT)
    Table 101. Middle East and Africa Asthma and COPD Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Asthma and COPD Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Asthma and COPD Drug Sales by Country (2017-2022) & (MT)
    Table 104. Middle East and Africa Asthma and COPD Drug Sales by Country (2023-2028) & (MT)
    Table 105. Middle East and Africa Asthma and COPD Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Asthma and COPD Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Boehringer Ingelheim Corporation Information
    Table 108. Boehringer Ingelheim Description and Major Businesses
    Table 109. Boehringer Ingelheim Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 110. Boehringer Ingelheim Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Boehringer Ingelheim Recent Developments
    Table 112. GlaxoSmithKline Corporation Information
    Table 113. GlaxoSmithKline Description and Major Businesses
    Table 114. GlaxoSmithKline Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 115. GlaxoSmithKline Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. GlaxoSmithKline Recent Developments
    Table 117. Merck and Co Corporation Information
    Table 118. Merck and Co Description and Major Businesses
    Table 119. Merck and Co Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 120. Merck and Co Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Merck and Co Recent Developments
    Table 122. Novartis AG Corporation Information
    Table 123. Novartis AG Description and Major Businesses
    Table 124. Novartis AG Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 125. Novartis AG Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Novartis AG Recent Developments
    Table 127. AstraZeneca Corporation Information
    Table 128. AstraZeneca Description and Major Businesses
    Table 129. AstraZeneca Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 130. AstraZeneca Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. AstraZeneca Recent Developments
    Table 132. F. Hoffmann-La Roche Corporation Information
    Table 133. F. Hoffmann-La Roche Description and Major Businesses
    Table 134. F. Hoffmann-La Roche Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 135. F. Hoffmann-La Roche Asthma and COPD Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. F. Hoffmann-La Roche Recent Developments
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Asthma and COPD Drug Distributors List
    Table 140. Asthma and COPD Drug Customers List
    Table 141. Asthma and COPD Drug Market Trends
    Table 142. Asthma and COPD Drug Market Drivers
    Table 143. Asthma and COPD Drug Market Challenges
    Table 144. Asthma and COPD Drug Market Restraints
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Asthma and COPD Drug Product Picture
    Figure 3. Global Asthma and COPD Drug Market Share by Type in 2021 & 2028
    Figure 3. Bronchodilators Product Picture
    Figure 4. Anti-inflammatory Drugs Product Picture
    Figure 5. Monoclonal Antibodies Product Picture
    Figure 6. Combination Drugs Product Picture
    Figure 7. Global Asthma and COPD Drug Market Share by Application in 2021 & 2028
    Figure 8. Asthma
    Figure 9. COPD
    Figure 10. Asthma and COPD Drug Report Years Considered
    Figure 11. Global Asthma and COPD Drug Sales 2017-2028 (MT)
    Figure 12. Global Asthma and COPD Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Asthma and COPD Drug Revenue 2017-2028 (US$ Million)
    Figure 14. Global Asthma and COPD Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Asthma and COPD Drug Sales Market Share by Region (2017-2022)
    Figure 16. Global Asthma and COPD Drug Sales Market Share by Region (2023-2028)
    Figure 17. North America Asthma and COPD Drug Sales YoY (2017-2028) & (MT)
    Figure 18. North America Asthma and COPD Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Asthma and COPD Drug Sales YoY (2017-2028) & (MT)
    Figure 20. Europe Asthma and COPD Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Asthma and COPD Drug Sales YoY (2017-2028) & (MT)
    Figure 22. Asia-Pacific Asthma and COPD Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Asthma and COPD Drug Sales YoY (2017-2028) & (MT)
    Figure 24. Latin America Asthma and COPD Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Asthma and COPD Drug Sales YoY (2017-2028) & (MT)
    Figure 26. Middle East & Africa Asthma and COPD Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Asthma and COPD Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Asthma and COPD Drug in the World: Market Share by Asthma and COPD Drug Revenue in 2021
    Figure 29. Global Asthma and COPD Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Asthma and COPD Drug Sales Market Share by Type (2017-2028)
    Figure 31. Global Asthma and COPD Drug Revenue Market Share by Type (2017-2028)
    Figure 32. Global Asthma and COPD Drug Sales Market Share by Application (2017-2028)
    Figure 33. Global Asthma and COPD Drug Revenue Market Share by Application (2017-2028)
    Figure 34. North America Asthma and COPD Drug Sales Market Share by Type (2017-2028)
    Figure 35. North America Asthma and COPD Drug Revenue Market Share by Type (2017-2028)
    Figure 36. North America Asthma and COPD Drug Sales Market Share by Application (2017-2028)
    Figure 37. North America Asthma and COPD Drug Revenue Market Share by Application (2017-2028)
    Figure 38. North America Asthma and COPD Drug Sales Share by Country (2017-2028)
    Figure 39. North America Asthma and COPD Drug Revenue Share by Country (2017-2028)
    Figure 40. U.S. Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Asthma and COPD Drug Sales Market Share by Type (2017-2028)
    Figure 43. Europe Asthma and COPD Drug Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Asthma and COPD Drug Sales Market Share by Application (2017-2028)
    Figure 45. Europe Asthma and COPD Drug Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Asthma and COPD Drug Sales Share by Country (2017-2028)
    Figure 47. Europe Asthma and COPD Drug Revenue Share by Country (2017-2028)
    Figure 48. Germany Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 49. France Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Asthma and COPD Drug Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Asthma and COPD Drug Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Asthma and COPD Drug Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Asthma and COPD Drug Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Asthma and COPD Drug Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Asthma and COPD Drug Revenue Share by Region (2017-2028)
    Figure 59. China Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. India Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Asthma and COPD Drug Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Asthma and COPD Drug Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Asthma and COPD Drug Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Asthma and COPD Drug Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Asthma and COPD Drug Sales Share by Country (2017-2028)
    Figure 74. Latin America Asthma and COPD Drug Revenue Share by Country (2017-2028)
    Figure 75. Mexico Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Asthma and COPD Drug Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Asthma and COPD Drug Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Asthma and COPD Drug Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Asthma and COPD Drug Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Asthma and COPD Drug Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Asthma and COPD Drug Revenue Share by Country (2017-2028)
    Figure 84. Turkey Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Asthma and COPD Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Asthma and COPD Drug Value Chain
    Figure 88. Asthma and COPD Drug Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer Ingelheim
GlaxoSmithKline
Merck and Co
Novartis AG
AstraZeneca
F. Hoffmann-La Roche
Frequently Asked Questions
Asthma and COPD Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Asthma and COPD Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Asthma and COPD Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports